Abstract
Quality by Design (QbD) started gaining momentum in the biotech industry after publication of the FDA's PAT—A Framework for Innovative Pharmaceutical Manufacturing and Quality Assurance and ICH Q8 through Q10. A significant amount of resources have been spent by the biotech industry and the
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: PDA Journal of Pharmaceutical Science and Technology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
